Skip to Content

Delzicol Approval History

FDA Approved: Yes (First approved February 1, 2013)
Brand name: Delzicol
Generic name: mesalamine
Dosage form: Delayed-Release Capsules
Company: Allergan plc
Treatment for: Ulcerative Colitis

Delzicol (mesalamine) is an aminosalicylate indicated for the treatment of mildly to moderately active ulcerative colitis and for the maintenance of remission of ulcerative colitis.

Development History and FDA Approval Process for Delzicol

DateArticle
Feb  6, 2013Approval Warner Chilcott Announces FDA Approval of New Ulcerative Colitis Product Delzicol

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide